Treatment of Familial Mediterranean Fever With Canakinumab in Patients Who Are Unresponsive to Colchicine

European Journal of Rheumatology
doi 10.5152/eurjrheum.2019.18190
Full Text
Abstract

Available in full text

Date
Authors
Publisher

AVES Publishing Co.

Related search

Assessment of Effectiveness of Anakinra and Canakinumab in Patients With Colchicine-Resistant/Unresponsive Familial Mediterranean Fever

Advances in Rheumatology
Rheumatology
2020English

Canakinumab Therapy in Patients With Familial Mediterranean Fever

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2015English

Colchicine Resistance and Low Vitamin D in Familial Mediterranean Fever

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2015English

Colchicine-And Clarithromycin-Induced Rhabdomyolysis in a Hemodialysis Patient With Familial Mediterranean Fever

Turkish Journal of Nephrology
2019English

Update on the Management of Colchicine Resistant Familial Mediterranean Fever (FMF)

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2019English

Canakinumab as Monotherapy for Treatment of Familial Mediterranean Fever – First Report in Central and Eastern Europe Region

Bratislava Medical Journal
2018English

Specific Changes in Faecal Microbiota Are Associated With Familial Mediterranean Fever

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2019English

Common MEFV Mutations in Palestinian Patients With Familial Mediterranean Fever

International Journal of Genetics and Genomics
2015English

Non-Periodic Leg Pain in Patients With Familial Mediterranean Fever

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy